The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications
|
Dec 2016
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
|
Oct 2013
|
Crit Rev Oncol Hematol
|
myelodysplastic syndromes (MDS)
|
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes
|
May 2023
|
Frontiers in Oncology
|
aplastic anemia
|
The Revised International Prognostic Scoring System (IPSS-R) is not Predictive of Survival in Patients with Secondary Myelodysplastic Syndromes
|
Apr 2015
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
|
Mar 2015
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
The Race for Survival in Myelodysplastic Syndromes
|
Sep 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion
|
Oct 2019
|
Annals of Hematology
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
|
Nov 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
The prognostic value of serum c-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
|
Aug 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
The Problem of TP53-Mutant MDS/AML
|
Sep 2020
|
Clinical Lymphoma , Myeloma & Leukemia
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|